AAAAAA
Results:
1-12
|
Results: 12
Authors:
MAMIYA K
IEIRI I
MIYAHARA S
IMAI J
FURUUMI H
FUKUMAKI Y
NINOMIYA H
TASHIRO N
YAMADA H
HIGUCHI S
Citation: K. Mamiya et al., ASSOCIATION OF POLYMORPHISMS IN THE CYTOCHROME-P450 (CYP) 2C19 AND 2C18 GENES IN JAPANESE EPILEPTIC PATIENTS, Pharmacogenetics, 8(1), 1998, pp. 87-90
Authors:
KIMURA M
IEIRI I
MAMIYA K
URAE F
HIGUCHI S
Citation: M. Kimura et al., GENETIC-POLYMORPHISM OF CYTOCHROME P450S, CYP2C19, AND CYP2C9 IN A JAPANESE POPULATION, Therapeutic drug monitoring, 20(3), 1998, pp. 243-247
Authors:
IEIRI I
MAMIYA K
URAE A
WADA Y
KIMURA M
IRIE S
AMAMOTO T
KUBOTA T
YOSHIOKA S
NAKAMURA K
NAKANO S
TASHIRO N
HIGUCHI S
Citation: I. Ieiri et al., STEREOSELECTIVE 4'-HYDROXYLATION OF PHENYTOIN - RELATIONSHIP TO (S)-MEPHENYTOIN POLYMORPHISM IN JAPANESE, British journal of clinical pharmacology, 43(4), 1997, pp. 441-445
Authors:
IEIRI I
NAKAYAMA J
MURAKAMI H
HORI Y
HIGUCHI S
Citation: I. Ieiri et al., EVALUATION OF THE THERAPEUTIC RANGE OF WHOLE-BLOOD CYCLOSPORINE CONCENTRATION IN THE TREATMENT OF PSORIASIS, International journal of clinical pharmacology and therapeutics, 34(3), 1996, pp. 106-111
Authors:
MORISHIGE H
SHUTO H
IEIRI I
OTSUBO K
OISHI R
Citation: H. Morishige et al., INSTABILITY OF STANDARD CALIBRATORS MAY BE INVOLVED IN OVERESTIMATINGVANCOMYCIN CONCENTRATIONS DETERMINED BY FLUORESCENCE POLARIZATION IMMUNOASSAY, Therapeutic drug monitoring, 18(1), 1996, pp. 80-85
Authors:
IEIRI I
MORIOKA T
KIM S
NISHIO S
FUKUI M
HIGUCHI S
Citation: I. Ieiri et al., PHARMACOKINETIC STUDY OF ZONISAMIDE IN PATIENTS UNDERGOING BRAIN SURGERY, Journal of Pharmacy and Pharmacology, 48(12), 1996, pp. 1270-1275
Authors:
IEIRI I
KUBOTA T
URAE A
KIMURA M
WADA Y
MAMIYA K
YOSHIOKA S
IRIE S
AMAMOTO T
NAKAMURA K
NAKANO S
HIGUCHI S
Citation: I. Ieiri et al., PHARMACOKINETICS OF OMEPRAZOLE (A SUBSTRATE OF CYP2C19) AND COMPARISON WITH 2 MUTANT ALLELES, C-UPSILON-P2C19(M1) IN EXON-5 AND C-UPSILON-P2C19(M2) IN EXON-4, IN JAPANESE SUBJECTS, Clinical pharmacology and therapeutics, 59(6), 1996, pp. 647-653
Authors:
IEIRI I
GOTO W
HIRATA K
TOSHITANI A
IMAYAMA S
OHYAMA Y
YAMADA H
OHTSUBO K
HIGUCHI S
Citation: I. Ieiri et al., THE EFFECT OF 5-(P-HYDROXYPHENYL)-5-PHENYLHYDANTOIN (P-HPPH) ENANTIOMERS, MAJOR METABOLITES OF PHENYTOIN, ON THE OCCURRENCE OF CHRONIC SIDE-EFFECTS - IN-VIVO AND IN-VITRO STUDIES, PSYCHIATRY AND CLINICAL NEUROSCIENCES, 49(3), 1995, pp. 247-251
Authors:
TASAKI K
MINAMI T
IEIRI I
OHTSUBO K
HIRAKAWA Y
UEDA K
HIGUCHI S
Citation: K. Tasaki et al., DRUG-INTERACTIONS OF ZONISAMIDE WITH PHENYTOIN AND SODIUM VALPROATE -SERUM CONCENTRATIONS AND PROTEIN-BINDING, Brain & development, 17(3), 1995, pp. 182-185
Authors:
IEIRI I
MORIOKA T
ICHIMIYA T
NISHIO S
FUKUI M
OHTSUBO K
HIGUCHI S
Citation: I. Ieiri et al., PHARMACOKINETIC STUDY OF VALPROIC ACID SUSTAINED-RELEASE PREPARATION IN PATIENTS UNDERGOING BRAIN SURGERY, Therapeutic drug monitoring, 17(1), 1995, pp. 6-11
Authors:
IEIRI I
GOTO W
HIRATA K
TOSHITANI A
IMAYAMA S
OHYAMA Y
YAMADA H
OHTSUBO K
HIGUCHI S
Citation: I. Ieiri et al., EFFECT OF 5-(P HYDROXYPHENYL)-5-PHENYLHYDANTOIN (P-HPPH) ENANTIOMERS,MAJOR METABOLITES OF PHENYTOIN, ON THE OCCURRENCE OF CHRONIC-GINGIVALHYPERPLASIA - IN-VIVO AND IN-VITRO STUDY, European Journal of Clinical Pharmacology, 49(1-2), 1995, pp. 51-56
Authors:
OHTSUBO K
HIRAKAWA Y
UEDA K
MINAMI T
IEIRI I
HIGUCHI S
AOYAMA T
Citation: K. Ohtsubo et al., INFLUENCE OF ADDITIONAL THERAPY WITH ZONISAMIDE (EXCEGRAN) ON PROTEIN-BINDING AND METABOLISM OF CARBAMAZEPINE, Epilepsia, 35(5), 1994, pp. 1023-1025
Risultati:
1-12
|